CareTrust REIT (CTRE) Q4 2025 earnings review
The Growth Engine is Firing on All Cylinders
CareTrust REIT delivered a mic drop quarter to cap off a transformative year. The company deployed a staggering $1.8 billion in 2025 (more than the prior 8 years combined), driving Normalized FFO per share up 17% YoY to $1.76. Despite this massive expansion, the balance sheet remains unloaded with leverage at a minuscule 0.7x, providing immense dry powder. Management's 2026 guidance projects another ~9.4% growth at the midpoint, signaling that the 'three-engine' strategy (US SNF, UK, SHOP) is working, though the law of large numbers means percentage growth is mathematically decelerating from 2025's breakout pace.
🐂 Bull Case
Net Debt to Annualized Run Rate EBITDA represents a historic low at 0.7x, vastly below the 4.0x-5.0x target range. With $1.2B in revolver capacity and $100M cash, CTRE can fund its entire $500M pipeline without raising a single dollar of equity if markets turn volatile.
Investment volume hit $1.8B in FY25 at a blended 8.6% yield. The pipeline remains robust at $500M. The entry into UK Care Homes and SHOP (Seniors Housing Operating Portfolio) proves the company can scale beyond its core US SNF competency.
🐻 Bear Case
The company is rapidly expanding into the UK and SHOP (operating) structures simultaneously. While Q4 results were good, managing three distinct growth engines increases operational complexity and G&A load ($52.5M in FY25 vs $28.9M in FY24).
To fund the $1.8B spree, CTRE issued massive equity (weighted average shares +31% YoY). If deal velocity slows, the weight of the expanded share count could dampen per-share growth rates.
⚖️ Verdict: 🟢🟢
Strong Buy. It is rare to see a REIT grow FFO/share by 17% while holding leverage near zero. CareTrust has effectively reset its baseline and possesses the capital flexibility to dominate in 2026 regardless of interest rate movements.
Key Themes
Unprecedented Investment Volume
FY25 was a breakout year for capital deployment. CareTrust invested $1.76B (plus loan funding), eclipsing the cumulative total of previous years. Critically, yields remain attractive at 8.6% blended for the year (8.8% in Q4). This volume is the primary driver of the 17% FFO/share growth despite significant share issuance.
Leverage as a Coiled Spring
Management has aggressively match-funded acquisitions with equity, driving Net Debt/EBITDA down to 0.7x (from 3.5x a year ago). This is essentially an unlevered balance sheet in a REIT structure. This provides massive optionality: they can lever up to the 4.0x-5.0x target to fund accretive deals, essentially creating 'free' growth capacity.
Tenant Concentration
While diversifying, exposure to The Ensign Group remains high at 23% of annualized rent. PACS Group represents 10%. While both are strong operators (Ensign EBITDAR coverage >3.0x), any idiosyncratic issue with these top tenants presents material risk.
UK & SHOP Integration
The diversification strategy is live. UK Care Homes now account for ~17% of annualized rent ($69M), and the first SHOP revenue appeared in Q4 ($1.2M). Management calls these new 'growth engines,' but they also introduce currency risk (GBP) and operational volatility (SHOP) not present in triple-net US SNF leases.
G&A Inflation
General & Administrative expenses nearly doubled YoY ($52.5M vs $28.9M). While necessary to support the new UK office and SHOP capabilities, this expense load is growing faster than revenue in the short term and needs to be monitored for stabilization.
Other KPIs
Accelerating. Up 18% YoY from $0.40 in 24Q4. Beat the sequential trend ($0.45 in Q3). Full year FFO of $1.76 landed near the high end of prior guidance.
Stable. Collection remains perfect for contractual rent and interest (exclusive of sold properties). This indicates underlying operator health despite broader industry headwinds.
Stable/Improving. Portfolio-wide coverage remains healthy at 2.22x. Skilled Nursing coverage is robust at 2.51x, while Senior Housing lags at 1.66x. The Top 10 operators are even stronger.
Guidance
Decelerating mathematically, but strong. The midpoint ($1.925) implies 9.4% growth over 2025's $1.76. While lower than the 17% jump in 2025, nearly 10% growth is top-tier for the sector. Guidance assumes NO new investments beyond year-to-date, making this a conservative floor.
Stable growth trajectory. Midpoint implies 9.4% growth over 2025 results ($1.76). Note that FFO and FAD are guided to the same range, indicating high quality of earnings with minimal non-cash adjustments dragging on cash flow.
Conservative. The guidance explicitly assumes 'No new investments' beyond those made year-to-date ($214.8M). Given the $500M pipeline and $1.2B liquidity, actual results should materially beat this guidance if deals close.
Key Questions
Leverage Strategy
With leverage at 0.7x against a 4.0x-5.0x target, are you planning a massive debt-funded portfolio acquisition, or is this simply conservatism due to equity market pricing?
SHOP Scalability
SHOP revenue was minimal in Q4. What is the target mix for SHOP assets in 2026, and how does the G&A burden ramp as you take on more operational exposure?
UK Currency Hedging
With UK assets now 17% of rent, how are you managing GBP/USD volatility, and is the current guidance sensitive to specific FX rate assumptions?